vimarsana.com

Latest Breaking News On - Chronic surface disease - Page 2 : vimarsana.com

Lifitegrast Mechanism of Action

Laura Periman, MD, describes the mechanism of action of lifitegrast for the treatment of dry eye disease.

Laura perimanDry eye diseaseOcular surfaceChronic surface diseaseInflammatory cellsInflammatory cascades

Lifitegrast Efficacy and Safety in Phase 3 Trials

Brandon Ayres, MD, provides an overview of lifitegrast efficacy and safety from the OPUS trials for the treatment of dry eye disease.

Brandon ayresDry eye diseaseOcular surfaceChronic surface diseaseInflammatory cellsInflammatory cascades

Dry Eye Disease Diagnosis

Experts provide an overview of the diagnostic process for identifying dry eye disease.

United statesKendall donaldsonLaura perimanDry eye diseaseOcular surfaceChronic surface disease

MGD Diagnosis

Experts discuss diagnosing meibomian gland dysfunction (MGD), the most common cause of dry eye disease.

United statesBrandon ayresLaura perimanEric donnenfeldKendall donaldsonI paul singhPaul singhDry eye diseaseOcular surfaceChronic surface diseaseArtificial tearTear filmTear breakup timeMeibomian gland dysfunctionComputer vision syndromePatient history

Prevalence and Risk Factors of Dry Eye Disease

Laura Periman, MD, discusses the prevalence and risk factors of dry eye disease.

Laura perimanDry eye diseaseRisk factorsDry eyeOcular surfaceChronic surface diseaseBlurry visionSurface drop loadOcular immunology

vimarsana © 2020. All Rights Reserved.